Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amgen
The objective of this non-interventional study is to describe patient reported outcomes, effectiveness and real-life use of apremilast treatment in patients with psoriatic arthritis (PsA).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Inclusion Criter
Patients ≥ 18 years of age who understand and voluntarily sign an informed consent form.
Patients starting treatment with apremilast for psoriatic arthritis.
You may not be if
Refusal to participate in the study.
Language barrier for completing the questionnaires.
Women who are pregnant or breast-feeding.
Hypersensitivity to the active substance or to any of the excipients.
Prior exposure to apremilast
Initiation of apremilast treatment by a dermatologist for psoriasis
